These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 527340)

  • 1. Serum prolactin concentrations related to copper or inert intrauterine devices (IUDs) in women.
    Ransom WT; Chapman RS; Hull MG
    Contraception; 1979 Nov; 20(5):441-6. PubMed ID: 527340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.
    Fylling P; Fagerhol M
    Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short notes on intrauterine devices.
    Indian J Med Sci; 1990 May; 44(5):129-33. PubMed ID: 2397950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intrauterine devices containing zinc and copper on their levels in serum.
    Anteby SO; Bassat HA; Yarkoni S; Aboulafia Y; Sadovsky E
    Fertil Steril; 1978 Jan; 29(1):30-4. PubMed ID: 620840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive cervical cancer and intrauterine device use.
    Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
    Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scanning and transmission electron microscopy of material adherent to intrauterine contraceptive devices.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):155-62. PubMed ID: 7362803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum copper in long-term users of copper intrauterine devices.
    Prema K; Lakshmi BA; Babu S
    Fertil Steril; 1980 Jul; 34(1):32-5. PubMed ID: 7398904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure responses of human endometrium to inert and copper IUDs as viewed by scanning electron microscopy.
    El-badrawi HH; Hafez ES; Fayad M; Shafeek A
    Contracept Deliv Syst; 1980 Apr; 1(2):103-11. PubMed ID: 12336235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative prolactin profiles in IUD users and non-IUD users.
    Adejuwon CA; Segal SJ; Faundes A; Alvarez-Sanchez F
    Contraception; 1982 Jun; 25(6):613-8. PubMed ID: 7116848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.